A substance that combines a monoclonal antibody (huN901) with an anticancer
drug (DM1), and is being studied in the treatment of certain cancers,
including non-small cell lung cancer. Monoclonal antibodies are
laboratory-produced substances that can locate and bind to cancer cells.